RETIN-A MICRO Rx
Generic Name and Formulations:
Tretinoin (in microspheres) 0.04%, 0.08%, 0.1%; aqueous gel.
Valeant Pharmaceuticals, Inc
Indications for RETIN-A MICRO:
Apply sparingly at bedtime to clean dry skin; adjust strength and frequency as tolerated and needed.
Not for use in eczema or sunburned skin. Avoid eyes, mouth, angles of nose, mucous membranes, sun, UV light. Discontinue if sensitivity reactions occur. Increased irritation in weather extremes. Gel: flammable. Pregnancy (Cat.C): not recommended. Nursing mothers.
Caution with concomitant topical medication, medicated or abrasive soaps/cleansers, astringents, drying agents, high-alcohol content topical products, spices. Avoid contact with peel of limes. Allow effects of benzoyl peroxide, sulfur, resorcinol, salicylic acid, other topical acne agents to subside before applying.
Local irritation, skin pain, pruritus, pharyngitis, erythema, transient symptom exacerbation or pigmentation changes, dryness, stinging, photosensitivity.
Micro 0.04%, 0.1%—20g, 45g, 50g; 0.08%—50g; Crm—20g, 45g; Gel—15g, 45g; Liq—28mL
Sign Up for Free e-newsletters
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- Age Not a Deterrent to Immunotherapy for Malignant Melanoma
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|